Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sunmax Biotechnology CoROCO:4728 +0.52%87 3-Year ROIIC % is 192.32 as of Dec. 2025, which is 184% above its 10-year median of 67.70. GuruFocus rates ROCO:4728 with a GF Score™ of 87/100 and a GF Value™ of NT$343.76 (Modestly Overvalued). The stock has 4 warning signs investors should review. Among 1,320 Biotechnology companies, Sunmax Biotechnology Co ranks better than 84.09% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Sunmax Biotechnology Co's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was 192.32%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Sunmax Biotechnology Co's 3-Year ROIIC % or its related term are showing as below:
ROCO:4728's 3-Year ROIIC % is ranked better than 84.09% of 1320
companies
in the Biotechnology industry
Industry Median: -4.835
vs ROCO:4728: 192.32
Sunmax Biotechnology Co (ROCO:4728) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Sunmax Biotechnology Co 3-Year ROIIC % Related Terms
Sunmax Biotechnology Co 3-Year ROIIC % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:4728 vs VRTX, REGN, RVMD: 3-Year ROIIC % Comparison
For the Biotechnology subindustry, Sunmax Biotechnology Co's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sunmax Biotechnology Co 3-Year ROIIC % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Sunmax Biotechnology Co's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Sunmax Biotechnology Co's 3-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Sunmax Biotechnology Co (ROCO:4728) has a 3-Year ROIIC % of 192.32 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Sunmax Biotechnology Co and its competitors. This is 184% above median its historical median of 67.70. Over the past decade, Sunmax Biotechnology Co's 3-Year ROIIC % has ranged from 11.93 to 192.32. According to the industry distribution chart, Sunmax Biotechnology Co ranks #210 out of 1320 companies in the Biotechnology industry, placing it in the top 15.9%.
Is Sunmax Biotechnology Co's 3-Year ROIIC % too high?
Sunmax Biotechnology Co's current 3-Year ROIIC % of 192.32 is 184% above median its 10-year median of 67.70. Over the past 10 years, this metric has ranged from a low of 11.93 to a high of 192.32. Based on the distribution chart, Sunmax Biotechnology Co ranks #210 out of 1320 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Sunmax Biotechnology Co has a GF Score™ of 87/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sunmax Biotechnology Co's 3-Year ROIIC % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Sunmax Biotechnology Co ranks #210 out of 1320 companies for 3-Year ROIIC %. This places Sunmax Biotechnology Co in the top 16% of its industry — outperforming the majority of peers. Historically, Sunmax Biotechnology Co's own 3-Year ROIIC % has ranged from 11.93 to 192.32 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Biotechnology company?
A good 3-Year ROIIC % depends on the Biotechnology industry context. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Sunmax Biotechnology Co and its competitors. Sunmax Biotechnology Co's current 3-Year ROIIC % is 192.32, which is 184% above median its own 10-year median of 67.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sunmax Biotechnology Co stock overvalued right now?
Based on GuruFocus' analysis, Sunmax Biotechnology Co (ROCO:4728) is currently considered Modestly Overvalued. The stock's GF Value™ is NT$343.76, compared to a current price of NT$383.00 — trading 11.4% above its estimated fair value. The current 3-Year ROIIC % is 192.32, which is 184% above median its 10-year median of 67.70. Sunmax Biotechnology Co's overall GF Score™ is 87/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Sunmax Biotechnology Co (ROCO:4728), the current 3-Year ROIIC % is 192.32 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sunmax Biotechnology Co (ROCO:4728) Overvalued in 2026?
Based on GuruFocus' analysis, Sunmax Biotechnology Co stock appears to be overvalued.
The current stock price of NT$383.00 is trading 11.4% above its estimated GF Value™ of NT$343.76.
GuruFocus considers Sunmax Biotechnology Co to be Modestly Overvalued.
Key valuation signals for ROCO:4728:
3-Year ROIIC %: 192.32 (184% above median its 10-year median of 67.70)
GF Value™: NT$343.76 vs. price of NT$383.00 (11.4% above fair value)
No single metric tells the full story. See the ROCO:4728 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sunmax Biotechnology Co Ltd is a biomedical company in Taiwan. It is engaged in the development, manufacturing, and commercialization of Sunmax medical devices and bio-surgical products. Additionally, it also researches, develops, manufactures and sales biomedical material grade collagen and related products. The company's products include medical products, biomedical materials, and porcine collagen skin care products.
87GF Score
Get the complete analysis for ROCO:4728
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4728 has been successfully added to your 
